Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|July 26, 2019
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaNicholas D Klemen, Melinda Wang, Paul L Feingold, et al.
Annals of Surgical Oncology|June 13, 2020
The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral MelanomaAnn Y Lee, Erica B Friedman, James Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Clinicopathologic predictors of sentinel lymph node metastasis in thin melanomaDale Han, Jonathan S Zager, Yu Shyr, et al.
American Journal of Surgery|February 20, 2025
Tumor infiltrating lymphocytes in primary melanoma are associated with a better prognosisSteven L Morrison, Gang Han, Faith Elenwa, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 9, 2021
Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival AnalysisAvani M Kolla, Gerardo A Vitiello, Erica B Friedman, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissectionZeynep Eroglu, Kristy K Broman, John F Thompson, et al.
Journal of the American College of Surgeons|December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched AnalysisKristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort studyCarl-Jacob Holmberg, Lars Ny, Tina J Hieken, et al.
Annals of Surgical Oncology|January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Pageof 6